Spark Investment Management LLC bought a new position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) during the second quarter, Holdings Channel reports. The fund bought 20,400 shares of the company’s stock, valued at approximately $1,232,000.

Several other hedge funds have also made changes to their positions in USPH. BlackRock Inc. boosted its stake in shares of U.S. Physical Therapy by 166,319.0% in the first quarter. BlackRock Inc. now owns 1,554,353 shares of the company’s stock worth $101,501,000 after buying an additional 1,553,419 shares during the period. Vanguard Group Inc. boosted its stake in shares of U.S. Physical Therapy by 6.5% in the first quarter. Vanguard Group Inc. now owns 641,533 shares of the company’s stock worth $41,892,000 after buying an additional 39,290 shares during the period. Aberdeen Asset Management PLC UK boosted its stake in shares of U.S. Physical Therapy by 11.0% in the first quarter. Aberdeen Asset Management PLC UK now owns 621,754 shares of the company’s stock worth $40,601,000 after buying an additional 61,715 shares during the period. Renaissance Technologies LLC boosted its stake in shares of U.S. Physical Therapy by 2.2% in the first quarter. Renaissance Technologies LLC now owns 605,000 shares of the company’s stock worth $39,506,000 after buying an additional 13,300 shares during the period. Finally, Dimensional Fund Advisors LP boosted its stake in shares of U.S. Physical Therapy by 0.9% in the first quarter. Dimensional Fund Advisors LP now owns 482,922 shares of the company’s stock worth $31,535,000 after buying an additional 4,361 shares during the period. Hedge funds and other institutional investors own 96.10% of the company’s stock.

U.S. Physical Therapy, Inc. (NYSE:USPH) opened at 63.05 on Thursday. The stock has a market cap of $793.04 million, a price-to-earnings ratio of 37.98 and a beta of 1.06. U.S. Physical Therapy, Inc. has a 52-week low of $51.96 and a 52-week high of $78.00. The stock has a 50 day moving average price of $62.60 and a 200 day moving average price of $66.14.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.60 by $0.01. U.S. Physical Therapy had a return on equity of 12.91% and a net margin of 5.65%. The firm had revenue of $104.25 million during the quarter, compared to analysts’ expectations of $102.93 million. Analysts expect that U.S. Physical Therapy, Inc. will post $2.14 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 8th. Stockholders of record on Monday, August 21st will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 1.27%. The ex-dividend date of this dividend is Thursday, August 17th. U.S. Physical Therapy’s payout ratio is 46.78%.

COPYRIGHT VIOLATION WARNING: “Spark Investment Management LLC Invests $1.23 Million in U.S. Physical Therapy, Inc. (USPH)” was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.watchlistnews.com/spark-investment-management-llc-invests-1-23-million-in-u-s-physical-therapy-inc-usph/1468053.html.

USPH has been the topic of a number of research reports. Zacks Investment Research cut shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Wednesday, June 21st. Barrington Research raised U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 price target for the company in a research report on Monday, July 3rd. Jefferies Group LLC reaffirmed a “hold” rating and issued a $63.00 price target on shares of U.S. Physical Therapy in a research report on Friday, June 30th. Cantor Fitzgerald began coverage on U.S. Physical Therapy in a research report on Monday, July 24th. They issued an “overweight” rating and a $72.00 price target for the company. Finally, BidaskClub lowered U.S. Physical Therapy from a “sell” rating to a “strong sell” rating in a research report on Sunday, July 16th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $68.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.